Resource type: Information leaflet
Publication type: Stroke information
You might be prescribed blood-thinning medication to reduce your risk of a TIA or stroke. This guide explains the two types of blood-thinning medication available, antiplatelets and anticoagulants, and how they are used after a stroke or for someone with atrial fibrillation.
Can training memory and attention on a home computer-task reduce spatial awareness problems after stroke?
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
On Monday 16th June the Stroke Association were invited to share how research we funded has changed lives at the All-Party Parliamentary Group on Medical Research Summer Reception, entitled, "A Healthy Future for UK Medical Research".
This study is investigating whether colchicine, a medication used to treat gout, could help to stop people who have previously had a stroke or TIA from having further strokes.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
The Medical Research Council (MRC) has launched a new £5m call for capital investment to support between two and five human tissue banks with linked data resources. Awards will be made to teams of academics working in close partnership with medical research charities.
The Stroke Association is pleased to support the AllTrials campaign and has signed the petition for all clinical trials to be registered and published.
Most stroke and transient ischaemic attack (TIA) survivors are asked to take medicines, which some can find difficult. However, taking the medicines prescribed after a stroke, or TIA, and following lifestyle advice can reduce the chance of another stroke by 80%.
The Stroke Association works with and for stroke survivors. We work with all stakeholders who have an interest in stroke, including the pharmaceutical industry, to achieve a common goal - to conquer stroke. Our guidelines ensure our approach to working with pharmaceutical companies is transparent and cannot compromise our independence.